Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on July 22, 2026

2 hours ago

Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

2 hours ago

Bunzl Canada Surpasses $2M Raised for Pediatric Brain Tumour Research

Indeterminate GlobeNewswire

2 hours ago

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

Indeterminate GlobeNewswire

2 hours ago

Bunzl Canada dépasse les 2 M$ amassés pour la recherche sur les tumeurs cérébrales pédiatriques

Indeterminate GlobeNewswire

2 hours ago

Supportive Cancer Care Takes Center Stage as Members of the National Coalition Together for Supportive Cancer Care Ring the Nasdaq Closing Bell

Indeterminate GlobeNewswire

2 hours ago

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

Indeterminate GlobeNewswire

2 hours ago

Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

Indeterminate GlobeNewswire

3 hours ago

Acentra Health Appoints Sreedevi Hegde as Senior Vice President – India Country Head

Indeterminate GlobeNewswire

4 hours ago

Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

Indeterminate GlobeNewswire

4 hours ago

ReBio Pharma appoints leading ocular oncologist Professor Mandeep Sagoo as Chief Medical Officer

Indeterminate GlobeNewswire

6 hours ago

Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma

Indeterminate GlobeNewswire

7 hours ago

Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline

Indeterminate GlobeNewswire

7 hours ago

Ipsen finalise l'acquisition de Memo Therapeutics AG, ajoutant un actif premier de sa classe au portefeuille de maladies rares d'Ipsen

Indeterminate GlobeNewswire

9 hours ago

Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

9 hours ago

GlycoReset Supplement Facts Released: Consumer Safety Report Details New Analysis About Glyco Reset Ingredients & Side Effects Risk

Indeterminate GlobeNewswire

11 hours ago

Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

Indeterminate GlobeNewswire